Option Care Health
Option Care Health is seeking a transformational and highly accomplished Senior Vice President, Specialty Operations to lead the strategic, operational, clinical, and financial performance of one of the nation's largest specialty pharmacy and specialty therapeutics platforms. This executive will be responsible for the end-to-end leadership of national specialty pharmacy operations, including specialty dispensing, patient services, access and reimbursement, revenue cycle management, buy-and-bill operations, pharmacy fulfillment, clinical operations, patient onboarding, digital enablement, and enterprise operational excellence. The ideal candidate is a nationally recognized specialty pharmacy executive with extensive experience scaling multi-site operations, leading large, distributed teams, driving EBITDA and operational performance, and transforming patient, provider, and employee experiences through technology, analytics, automation, and continuous improvement.
Headquarters
Bannockburn, Illinois, United States
Company Size
5001-10000 employees
Founded
1979
The leading provider of home infusion services, Option Care Health strives to improve quality of care and reduce patient healthcare costs.
Option Care Health, Inc. $OPCH Shares Bought by Victory Capital Management Inc.
2 hours ago
Option Care Health, CooperCompanies, Neogen, GoodRx, and Fortrea Shares Are Falling, What You Need To Know
5 days ago
Option Care Health, CooperCompanies, Neogen, GoodRx, and Fortrea Shares Are Falling, What You Need To Know
5 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Option Care Health.
11% above the average for this role
Option Care Health Growth Story Faces Debt And Biosimilar Pressures
2 weeks ago